ArticleHuman brain mapping2025
Dynamic and Static Structure-Function Coupling With Machine Learning for the Early Detection of Alzheimer's Disease.
Article in Human brain mapping, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Shannon Entropy of Gray Matter Eigenmodes: A Novel Biomarker for Alzheimer's Disease and Heterogeneous MCI Trajectories.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The progression of Alzheimer's disease (AD) involves complex changes in brain structure and function that are driven by their interaction, making structure-function coupling (SFC) a valuable indicator for early detection of AD. Static SFC refers to the overall structure-function interaction, whereas dynamic SFC refers to transient coupling variations. In this study, we aimed to assess the potential of combining static and dynamic SFC with machine learning (ML) for the early detection of AD. We analyzed a discovery cohort and an external validation cohort, including AD, mild cognitive impairment (MCI), and healthy control (HC) groups. Then, we quantified differences between static SFC and dynamic SFC at different stages of AD progression. Feature selection was performed using ElasticNet. A Gaussian naive Bayes (GNB) classifier was used to test the ability of SFC to classify AD stages. We also analyzed the correlations between SFC features and early AD physiological biomarkers. Static SFC increased with AD progression, whereas dynamic SFC showed greater variability and decreased stability. Using SFC features selected by ElasticNet, the GNB classifier achieved high performance in differentiating between the HC and MCI stages (area under the curve [AUC] = 91.1%) and between the MCI and AD stages (AUC = 89.03%). Significant correlations were found between SFC features and physiological biomarkers. The combined use of SFC features and ML has strong potential value for the accurate classification of AD stages and significant potential value for the early detection of AD. This study demonstrates that combining static and dynamic SFC with ML provides a novel perspective for understanding the mechanisms of AD and contributes to improving its early detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.